Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface

Erik R. Nelson, Shenduo Li, Margaret Kennedy, Sturgis Payne, Kelly Kilibarda, Jeffrey Groth, Michelle Bowie, Edgardo Parilla-Castellar, Gustaaf de Ridder, Paul Kelly Marcom, Matthew Lyes, Bercedis L. Peterson, Michael Cook, Salvatore V. Pizzo, Donald P. McDonnell, Robin E. Bachelder

Research output: Contribution to journalArticle

Abstract

Background: Although most triple-negative breast cancer (TNBC) patients initially respond to chemotherapy, residual tumor cells frequently persist and drive recurrent tumor growth. Previous studies from our laboratory and others' indicate that TNBC is heterogeneous, being composed of chemo-sensitive and chemo-resistant tumor cell subpopulations. In the current work, we studied the invasive behaviors of chemoresistant TNBC, and sought to identify markers of invasion in chemo-residual TNBC. Methods: The invasive behavior of TNBC tumor cells surviving short-term chemotherapy treatment in vitro was studied using transwell invasion assays and an experimental metastasis model. mRNA expression levels of neural cadherin (N-cadherin), an adhesion molecule that promotes invasion, was assessed by PCR. Expression of N-cadherin and its precursor form (pro-N-cadherin) was assessed by immunoblotting and flow cytometry. Pro-N-cadherin immunohistochemistry was performed on tumors obtained from patients pre- and post- neoadjuvant chemotherapy treatment. Results: TNBC cells surviving short-term chemotherapy treatment exhibited increased invasive behavior and capacity to colonize metastatic sites compared to untreated tumor cells. The invasive behavior of chemo-resistant cells was associated with their increased cell surface expression of precursor N-cadherin (pro-N-cadherin). An antibody specific for the precursor domain of N-cadherin inhibited invasion of chemo-resistant TNBC cells. To begin to validate our findings in humans, we showed that the percent cell surface pro-N-cadherin (+) tumor cells increased in patients post- chemotherapy treatment. Conclusions: TNBC cells surviving short-term chemotherapy treatment are more invasive than bulk tumor cells. Cell surface pro-N-cadherin expression is associated with the invasive and chemo-resistant behaviors of this tumor cell subset. Our findings indicate the importance of future studies determining the value of cell surface pro-N-cadherin as: 1) a biomarker for TNBC recurrence and 2) a therapeutic target for eliminating chemo-residual disease.

Original languageEnglish (US)
Pages (from-to)84030-84042
Number of pages13
JournalOncotarget
Volume7
Issue number51
DOIs
StatePublished - Jan 1 2016

Fingerprint

Cadherins
Triple Negative Breast Neoplasms
Breast Neoplasms
Drug Therapy
Neoplasms
Therapeutics
Neoadjuvant Therapy
Residual Neoplasm
Immunoblotting
Flow Cytometry
Theoretical Models

Keywords

  • Chemotherapy resistance
  • Invasion
  • Metastasis
  • Precursor-N-cadherin
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface. / Nelson, Erik R.; Li, Shenduo; Kennedy, Margaret; Payne, Sturgis; Kilibarda, Kelly; Groth, Jeffrey; Bowie, Michelle; Parilla-Castellar, Edgardo; de Ridder, Gustaaf; Marcom, Paul Kelly; Lyes, Matthew; Peterson, Bercedis L.; Cook, Michael; Pizzo, Salvatore V.; McDonnell, Donald P.; Bachelder, Robin E.

In: Oncotarget, Vol. 7, No. 51, 01.01.2016, p. 84030-84042.

Research output: Contribution to journalArticle

Nelson, ER, Li, S, Kennedy, M, Payne, S, Kilibarda, K, Groth, J, Bowie, M, Parilla-Castellar, E, de Ridder, G, Marcom, PK, Lyes, M, Peterson, BL, Cook, M, Pizzo, SV, McDonnell, DP & Bachelder, RE 2016, 'Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface', Oncotarget, vol. 7, no. 51, pp. 84030-84042. https://doi.org/10.18632/oncotarget.12767
Nelson, Erik R. ; Li, Shenduo ; Kennedy, Margaret ; Payne, Sturgis ; Kilibarda, Kelly ; Groth, Jeffrey ; Bowie, Michelle ; Parilla-Castellar, Edgardo ; de Ridder, Gustaaf ; Marcom, Paul Kelly ; Lyes, Matthew ; Peterson, Bercedis L. ; Cook, Michael ; Pizzo, Salvatore V. ; McDonnell, Donald P. ; Bachelder, Robin E. / Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface. In: Oncotarget. 2016 ; Vol. 7, No. 51. pp. 84030-84042.
@article{4c58604ab3244cf3a821544a26867bd2,
title = "Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface",
abstract = "Background: Although most triple-negative breast cancer (TNBC) patients initially respond to chemotherapy, residual tumor cells frequently persist and drive recurrent tumor growth. Previous studies from our laboratory and others' indicate that TNBC is heterogeneous, being composed of chemo-sensitive and chemo-resistant tumor cell subpopulations. In the current work, we studied the invasive behaviors of chemoresistant TNBC, and sought to identify markers of invasion in chemo-residual TNBC. Methods: The invasive behavior of TNBC tumor cells surviving short-term chemotherapy treatment in vitro was studied using transwell invasion assays and an experimental metastasis model. mRNA expression levels of neural cadherin (N-cadherin), an adhesion molecule that promotes invasion, was assessed by PCR. Expression of N-cadherin and its precursor form (pro-N-cadherin) was assessed by immunoblotting and flow cytometry. Pro-N-cadherin immunohistochemistry was performed on tumors obtained from patients pre- and post- neoadjuvant chemotherapy treatment. Results: TNBC cells surviving short-term chemotherapy treatment exhibited increased invasive behavior and capacity to colonize metastatic sites compared to untreated tumor cells. The invasive behavior of chemo-resistant cells was associated with their increased cell surface expression of precursor N-cadherin (pro-N-cadherin). An antibody specific for the precursor domain of N-cadherin inhibited invasion of chemo-resistant TNBC cells. To begin to validate our findings in humans, we showed that the percent cell surface pro-N-cadherin (+) tumor cells increased in patients post- chemotherapy treatment. Conclusions: TNBC cells surviving short-term chemotherapy treatment are more invasive than bulk tumor cells. Cell surface pro-N-cadherin expression is associated with the invasive and chemo-resistant behaviors of this tumor cell subset. Our findings indicate the importance of future studies determining the value of cell surface pro-N-cadherin as: 1) a biomarker for TNBC recurrence and 2) a therapeutic target for eliminating chemo-residual disease.",
keywords = "Chemotherapy resistance, Invasion, Metastasis, Precursor-N-cadherin, Triple-negative breast cancer",
author = "Nelson, {Erik R.} and Shenduo Li and Margaret Kennedy and Sturgis Payne and Kelly Kilibarda and Jeffrey Groth and Michelle Bowie and Edgardo Parilla-Castellar and {de Ridder}, Gustaaf and Marcom, {Paul Kelly} and Matthew Lyes and Peterson, {Bercedis L.} and Michael Cook and Pizzo, {Salvatore V.} and McDonnell, {Donald P.} and Bachelder, {Robin E.}",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.12767",
language = "English (US)",
volume = "7",
pages = "84030--84042",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "51",

}

TY - JOUR

T1 - Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface

AU - Nelson, Erik R.

AU - Li, Shenduo

AU - Kennedy, Margaret

AU - Payne, Sturgis

AU - Kilibarda, Kelly

AU - Groth, Jeffrey

AU - Bowie, Michelle

AU - Parilla-Castellar, Edgardo

AU - de Ridder, Gustaaf

AU - Marcom, Paul Kelly

AU - Lyes, Matthew

AU - Peterson, Bercedis L.

AU - Cook, Michael

AU - Pizzo, Salvatore V.

AU - McDonnell, Donald P.

AU - Bachelder, Robin E.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Although most triple-negative breast cancer (TNBC) patients initially respond to chemotherapy, residual tumor cells frequently persist and drive recurrent tumor growth. Previous studies from our laboratory and others' indicate that TNBC is heterogeneous, being composed of chemo-sensitive and chemo-resistant tumor cell subpopulations. In the current work, we studied the invasive behaviors of chemoresistant TNBC, and sought to identify markers of invasion in chemo-residual TNBC. Methods: The invasive behavior of TNBC tumor cells surviving short-term chemotherapy treatment in vitro was studied using transwell invasion assays and an experimental metastasis model. mRNA expression levels of neural cadherin (N-cadherin), an adhesion molecule that promotes invasion, was assessed by PCR. Expression of N-cadherin and its precursor form (pro-N-cadherin) was assessed by immunoblotting and flow cytometry. Pro-N-cadherin immunohistochemistry was performed on tumors obtained from patients pre- and post- neoadjuvant chemotherapy treatment. Results: TNBC cells surviving short-term chemotherapy treatment exhibited increased invasive behavior and capacity to colonize metastatic sites compared to untreated tumor cells. The invasive behavior of chemo-resistant cells was associated with their increased cell surface expression of precursor N-cadherin (pro-N-cadherin). An antibody specific for the precursor domain of N-cadherin inhibited invasion of chemo-resistant TNBC cells. To begin to validate our findings in humans, we showed that the percent cell surface pro-N-cadherin (+) tumor cells increased in patients post- chemotherapy treatment. Conclusions: TNBC cells surviving short-term chemotherapy treatment are more invasive than bulk tumor cells. Cell surface pro-N-cadherin expression is associated with the invasive and chemo-resistant behaviors of this tumor cell subset. Our findings indicate the importance of future studies determining the value of cell surface pro-N-cadherin as: 1) a biomarker for TNBC recurrence and 2) a therapeutic target for eliminating chemo-residual disease.

AB - Background: Although most triple-negative breast cancer (TNBC) patients initially respond to chemotherapy, residual tumor cells frequently persist and drive recurrent tumor growth. Previous studies from our laboratory and others' indicate that TNBC is heterogeneous, being composed of chemo-sensitive and chemo-resistant tumor cell subpopulations. In the current work, we studied the invasive behaviors of chemoresistant TNBC, and sought to identify markers of invasion in chemo-residual TNBC. Methods: The invasive behavior of TNBC tumor cells surviving short-term chemotherapy treatment in vitro was studied using transwell invasion assays and an experimental metastasis model. mRNA expression levels of neural cadherin (N-cadherin), an adhesion molecule that promotes invasion, was assessed by PCR. Expression of N-cadherin and its precursor form (pro-N-cadherin) was assessed by immunoblotting and flow cytometry. Pro-N-cadherin immunohistochemistry was performed on tumors obtained from patients pre- and post- neoadjuvant chemotherapy treatment. Results: TNBC cells surviving short-term chemotherapy treatment exhibited increased invasive behavior and capacity to colonize metastatic sites compared to untreated tumor cells. The invasive behavior of chemo-resistant cells was associated with their increased cell surface expression of precursor N-cadherin (pro-N-cadherin). An antibody specific for the precursor domain of N-cadherin inhibited invasion of chemo-resistant TNBC cells. To begin to validate our findings in humans, we showed that the percent cell surface pro-N-cadherin (+) tumor cells increased in patients post- chemotherapy treatment. Conclusions: TNBC cells surviving short-term chemotherapy treatment are more invasive than bulk tumor cells. Cell surface pro-N-cadherin expression is associated with the invasive and chemo-resistant behaviors of this tumor cell subset. Our findings indicate the importance of future studies determining the value of cell surface pro-N-cadherin as: 1) a biomarker for TNBC recurrence and 2) a therapeutic target for eliminating chemo-residual disease.

KW - Chemotherapy resistance

KW - Invasion

KW - Metastasis

KW - Precursor-N-cadherin

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=85007482746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007482746&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.12767

DO - 10.18632/oncotarget.12767

M3 - Article

C2 - 27768598

AN - SCOPUS:85007482746

VL - 7

SP - 84030

EP - 84042

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 51

ER -